Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy

Abstract

High intracellular reactive oxygen species (ROS) level is characteristic of cancer cells and could act as a target for the efficient targeted drug delivery for cancer treatment. Consequently, biomaterials that react to excessive levels of ROS are essential for biomedical applications. In this study, a novel ROS-responsive polymer based on D-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS) and poly (β-thioester) (TPGS-PBTE) was synthesized for targeted delivery of the first-line antineoplastic drug, paclitaxel (PTX). The resultant TPGS-PBTE NPs showed good ROS-responsive capability in size change and drug release. Compared to PTX, PTX-loaded nanoparticles (PTX@TPGS-PBTE NPs) showed enhanced cytotoxicity and higher level of apoptosis toward squamous cell carcinoma (SCC-7) cells. Tumor-targeted delivery of the NPs was also observed, especially after being modified with a tumor-targeting peptide, cRGD. Enhanced tumor growth inhibition was also observed in head and neck cancer SCC-7 murine models. In summary, PTX@TPGS-PBTE NPs can achieve good therapeutic effects of PTX against head and neck cancer both in vitro and in vivo, especially when modified by cRGD for active targeting, which enriched the application of ROS responsive system utilized in the delivery of anticancer drugs.

GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38/JNK MAPK pathway activation and mitochondrial apoptosis

“…It has been demonstrated in many kinds of cancers that inducing ROS production could induce cells apoptosis and prevent cancer cell proliferation and metastasis. Some ROS-promoting drugs showed inhibitory effect on HCC cells proliferation and tumor growth, which are expected to be candidates for clinical treatment of HCC, such as sorafenib, paclitaxel, curcumin, 5-fluorouracil, and so on [32][33][34][35]. Therefore, ROS content enhancement of cancer cells is an important and promising strategy for clinical treatment of HCC.…”

ROS Responsive Nanoparticles Encapsulated with Natural Medicine Remodel Autophagy Homeostasis in Breast Cancer

“…The synthesis details of DSPE-tk-PEG was described in Supporting Information. The reason the TK bond was chosen for synthesis of ROS responsive bond was that the TK bond had better biosafety and stability when compared with thioether and arylboronic esters. − After DSPE-tk-PEG was synthesized, 2 mg of triptolide (TP) and 1 mg of AIE molecules were dissolved in 2 mL of anhydrous dichloromethane, and 10 mg of DSPE-tk-PEG was dissolved in 5 mL of deionized water (ddH 2 O). The organic phase was added into the aqueous phase drop by drop under vigorous stirring at room temperature, and then the solution was sonicated by a probe type ultrasonic instrument at 0 °C for 15 min (min).…”

The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts

“…184 Self-polymerizing micelles containing cyclopamine (CPA) and PTX can reshape the TME by regulating Hedgehog signaling. 169,222 NPs generated using the cellax-DTX polymer (with a size of 120 nm), specifically accumulate in α-SMA + CAFs, leading to their depletion. This strategy reduces the density of the TME, consequently increasing tissue perfusion.…”